KYMR · Forms 3, 4, 5

Insider trades at Kymera Therapeutics, Inc.

1 insider sold $3.4M of Kymera Therapeutics, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Kymera Therapeutics, Inc. (KYMR) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Nello MainolfiChief Executive OfficerOption exercise30,000$2.08$62KForm 4
Nello MainolfiChief Executive OfficerSell3,525$111.44$393KForm 4
Nello MainolfiChief Executive OfficerSell5,506$112.42$619KForm 4
Nello MainolfiChief Executive OfficerSell4,876$113.24$552KForm 4
Nello MainolfiChief Executive OfficerSell7,601$114.43$870KForm 4
Nello MainolfiChief Executive OfficerSell8,230$115.40$950KForm 4
Nello MainolfiChief Executive OfficerSell262$116.12$30KForm 4
Brian AdamsChief Legal OfficerSell1,209$115.55$140KForm 4
Brian AdamsChief Legal OfficerSell3,025$116.81$353KForm 4
Brian AdamsChief Legal OfficerSell2,137$117.57$251KForm 4
Terence RooneyChief Medical OfficerAward38,000Form 4
Terence RooneyChief Medical OfficerBecame an insider (Form 3)Form 3

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.